Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles 
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness 
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
MONTPELLIER, France, Jan. 19, 2016 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, has announced the appointment of Teresa Prego to the position of Director of Marketing.
Based at Medtech’s U.S. branch, Ms. Prego will develop and implement the Company’s marketing policy, with a strong focus on supporting commercial operations in the U.S.. This includes the marketing strategy and commercial launch of the ROSA™ Spine robot in the U.S., which recently received 510K clearance from the U.S. Food and Drug Administration (FDA).
Ms. Prego has had more than 20 years of experience in strategic marketing within the medical field. Prior to Medtech, she served as a Senior Consultant at Andersen Consulting (now Accenture), held roles with Bayer, Boston Scientific, Aspect Medical and, most recently, was the Marketing Director at Tenet Healthcare.
“Teresa Prego’s marketing experience and expertise in the U.S. medical sector are major assets for Medtech,” said Bertin Nahum, CEO and Founder of Medtech. “Her appointment will contribute to driving adoption of our technology in various markets, including the launch of ROSA Spine in the U.S. True to the commitments we made at the time of the IPO, we are successfully executing on our growth strategy with additions to the management team to keep pace with the expansion of our commercial activity.”
| About MEDTECH | ||
| Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment. In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada. In 2013 MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan. In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine. In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards. In 2015 MEDTECH received the “2016 Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan. In November 2015, MEDTECH was honored by Deloitte In Extenso for its excellent performance in the Technology Fast 50 Mediterranean Awards, in the “listed company” category. In January 2016, MEDTECH obtained the FDA clearance for its new product, ROSA™ Spine, a robotic-assistive device for minimally invasive surgery of the spine. | ||
CONTACT MEDTECH Christophe Sibillin Chief Financial Officer Tel : +33 (0)4 67 10 77 40 INVESTORS Corinne Puissant Tel : +33 (0)1 53 67 36 77 [email protected] PRESS Alexandra Prisa (EU) Tel. : +33(0)1 53 67 36 90 [email protected] Joanna Zimmerman (US) Tel : +1 646-536-7006 [email protected]
